STAT Reports

Ranking biotech's top venture capital firms

$499.00

Ranking biotech's top venture capital firms
License Type:

Which venture capital firms get the best returns? STAT’s Kate Sheridan did some digging and has a definitively ranked list for more than a dozen of the biggest names in biotech investment: including Third Rock Ventures, OrbiMed, ARCH Venture Partners, and even Flagship Pioneering. 

For this latest, 50-page STAT Report, she combed through returns data — normally private, now made available through Freedom of Information Act requests and certain public records. Alongside a ranking of the firms that are most relevant to biotech investors, she’s also included a deep dive into each firm on the list — explaining the strategies behind their performance, the drugs and companies in which they’ve invested, and the people who are making key decisions.

    How it works

    Add this report to your cart, and then complete the checkout process. Once you have, you'll receive an email with the link to download the full report file. This report is digital-only, so you will not receive a printout.

    Preview

    Take a peek at what's included in this report.